schizophrenia
idiopath
disord
affect
approxim
human
popul
present
persist
delus
hallucin
disorgan
behavior
antipsychot
standard
pharmacolog
treatment
schizophrenia
frequent
discontinu
patient
due
inefficaci
andor
side
effect
chronic
treatment
typic
antipsychot
haloperidol
caus
tardiv
dyskinesia
td
manifest
involuntari
often
irrevers
orofaci
movement
around
patient
mice
treat
haloperidol
develop
mani
featur
td
includ
jaw
tremor
tongu
protrus
vacuou
chew
movement
vcm
studi
use
genet
divers
collabor
cross
cc
recombin
inbr
intercross
rix
mice
elucid
genet
basi
antipsychoticinduc
advers
drug
reaction
adr
perform
batteri
behavior
test
mice
rix
line
deriv
cc
strain
treat
haloperidol
placebo
order
monitor
develop
adr
use
linear
mix
model
test
strain
treatment
effect
observ
highli
signific
strain
effect
almost
behavior
measur
investig
p
observ
strong
strainbytreat
interact
phenotyp
particularli
chang
distanc
travel
vertic
activ
extrapyramid
symptom
ep
estim
overal
herit
rang
chang
bodi
weight
vcm
chang
distanc
travel
portion
attribut
interact
treatment
strain
rang
chang
bodi
weight
chang
ep
interestingli
close
rix
mice
exhibit
vcm
sensit
haloperidol
exposur
approxim
similar
rate
td
human
chronic
expos
haloperidol
schizophrenia
chronic
sever
disabl
brain
disord
affect
popul
worldwid
associ
substanti
morbid
mortal
person
societ
cost
saha
et
al
world
health
organ
laursen
et
al
cloutier
et
al
onset
typic
occur
adolesc
earli
adulthood
emerg
number
symptom
includ
hallucin
delus
disorgan
behavior
american
psychiatr
associ
antipsychot
medic
mainstay
treatment
schizophrenia
much
patient
discontinu
assign
treatment
due
side
effect
andor
inefficaci
rel
short
period
time
lieberman
et
al
deciph
pharmacogenet
antipsychot
could
eventu
allow
develop
predict
algorithm
physician
could
predict
patient
prone
develop
side
effect
less
like
achiev
therapeut
respons
advanc
arena
could
lead
safer
efficaci
therapeut
intervent
treatment
schizophrenia
haloperidol
highpot
typic
firstgener
antipsychot
whose
use
associ
motor
advers
drug
reaction
adr
includ
tardiv
dyskinesia
soaresweis
fernandez
involuntari
orofaci
movement
extrapyramid
symptom
ie
dystonia
parkinson
miller
et
al
substanti
interindividu
variat
liabil
adr
direct
indirect
evid
suggest
role
genet
variat
lerer
et
al
patsopoulo
et
al
bakker
et
al
signific
heterogen
therapeut
respons
antipsychot
lieberman
et
al
roughli
equal
proport
patient
experienc
remiss
partial
respons
benefit
vacuou
chew
movement
vcm
present
rodent
purposeless
mouth
open
vertic
plane
valid
rodent
model
human
pharmacogenet
phenotyp
tardiv
tradit
recombin
inbr
strain
gener
cross
two
parent
inbr
strain
follow
gener
inbreed
brothersist
mate
lack
genet
divers
limit
number
avail
strain
eg
balbc
etc
contrast
collabor
cross
cc
threadgil
et
al
churchil
et
al
collabor
cross
consortium
panel
recombin
inbr
ri
mous
strain
deriv
eight
founder
laboratori
strain
design
optim
murin
model
heterogen
human
popul
churchil
et
al
aylor
et
al
threadgil
et
al
collabor
cross
consortium
cc
captur
complex
mammalian
genom
import
resourc
map
complex
trait
system
genet
effort
aylor
et
al
kelada
et
al
ferri
et
al
gralinski
et
al
gralinski
et
al
shorter
et
al
srivastava
et
al
cc
also
sourc
new
model
human
diseas
rogala
et
al
graham
et
al
mcmullan
et
al
orgel
et
al
mate
differ
cc
strain
gener
recombin
inbr
intercross
ccrix
zou
et
al
schoenrock
et
al
ccrix
outbr
genom
complet
reproduc
mate
parent
cc
strain
thu
intrigu
model
genet
divers
akin
human
popul
zou
et
al
liu
et
al
genet
divers
ccrix
enabl
studi
parentoforigin
effect
phenotyp
character
demonstr
strong
strain
effect
measur
crowley
et
al
schoenrock
et
al
use
standard
inbr
line
previous
demonstr
could
effect
deliv
haloperidol
humanlik
steadyst
concentr
steadyst
plasma
haloperidol
concentr
trait
rel
high
herit
substanti
ri
strain
differ
vulner
vcm
crowley
et
al
crowley
et
al
crowley
et
al
studi
gener
mice
perform
extens
phenotyp
character
mice
repres
rix
line
chronic
treat
haloperidol
placebo
order
gain
insight
genet
basi
adr
perform
batteri
behavior
test
includ
open
field
activ
inclin
screen
test
video
record
vcm
order
examin
strain
treatment
effect
chronic
haloperidol
exposur
use
linear
mix
model
show
rix
line
exhibit
strong
strain
effect
strainbytreat
interact
support
hypothesi
signific
differenti
contribut
genet
background
haloperidolinduc
adr
fact
rix
line
display
rang
respons
haloperidolinduc
adr
distribut
compar
suscept
haloperidoladr
human
popul
support
use
model
studi
pharmacogenom
addit
phenotyp
comfort
posit
mous
collar
partial
immobil
mice
neck
still
permit
head
movement
allow
video
record
jaw
movement
jvc
everio
digit
camcord
digit
videotap
made
use
protocol
develop
tomiyama
et
al
tomiyama
et
al
first
minut
video
analyz
order
allow
mice
adjust
collar
relax
last
minut
video
score
orofaci
movement
video
random
score
singleblind
rater
increas
consist
reduc
deviat
bia
rater
rater
train
expert
set
standard
train
video
use
studi
crowley
et
al
crowley
et
al
crowley
et
al
align
rater
correct
identif
vcm
accord
score
previou
studi
drift
monitor
rescor
random
video
throughout
cours
studi
movement
specif
analyz
count
tongu
protrus
jaw
tremor
overt
chew
movement
subtl
chew
movement
individu
event
movement
count
subtl
chew
movement
defin
instanc
vertic
jaw
movement
insid
caviti
mouth
could
seen
jaw
open
long
period
time
overt
chew
movement
occur
larger
vertic
movement
observ
caviti
could
seen
jaw
open
extend
length
time
video
score
use
observ
xt
noldu
inc
wageningen
netherland
observ
data
analysi
program
previou
work
crowley
et
al
shown
inbr
strain
treat
chronic
haloperidol
behavior
domain
measur
load
onto
two
factor
rather
discret
construct
crowley
et
al
one
factor
load
primarili
antipsychoticinduc
chang
open
field
activ
load
primarili
haloperidolinduc
orofaci
movement
studi
collaps
four
vcm
measur
singl
factor
tissu
collect
mice
sacrif
day
rel
start
drug
treatment
cervic
disloc
collect
blood
plasma
haloperidoltr
mice
time
use
edtatr
tube
order
measur
haloperidol
drug
concentr
blood
centrifug
isol
plasma
haloperidol
assay
perform
use
mass
spectrometri
analyt
psychopharmacolog
laboratori
locat
nathan
kline
institut
psychiatr
research
orangeburg
ny
usa
statist
model
shown
tabl
phenotyp
studi
group
three
class
depend
natur
outcom
ascertain
correspondingli
three
separ
statist
model
employ
open
field
activ
ep
bodi
mass
phenotyp
outcom
ascertain
two
occas
preand
posttreat
ccbi
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
arm
vcm
measur
singl
occas
posttreat
arm
blood
plasma
phenotyp
also
measur
posttreat
natur
appli
haloperidol
arm
open
field
ep
bodi
weight
phenotyp
differ
preand
posttreat
measur
taken
logtransform
bodi
weight
mix
model
employ
phenotyp
refer
vector
transform
respons
pretreat
phenotyp
valu
vector
treatment
indic
control
sex
control
interact
sex
treatment
refer
random
effect
vector
associ
th
random
effect
correspond
batch
strain
strainbytreat
strainbysex
strainbysexbytreat
effect
henceforth
refer
effect
respect
assum
mutual
independ
error
term
independ
random
effect
detail
construct
associ
random
design
matric
includ
file
singl
vcm
phenotyp
deriv
sum
number
subtl
overt
vcm
tongu
movement
tremor
phenotyp
follow
model
employ
term
control
pretreat
valu
exclud
follow
haloperidol
blood
concentr
logtransform
follow
model
employ
model
control
three
random
effect
batch
strain
sex
http
csbiounceduccstatusindexpi
runavailablelin
supplement
file
avail
figshar
tabl
describ
cc
strain
use
gener
rix
line
part
studi
figur
show
mate
scheme
use
cross
cc
gener
rix
maximum
genet
divers
figur
show
haloperidolinduc
chang
behavior
measur
figur
show
raw
data
rix
mice
treat
haloperidol
placebo
centroid
time
stereotypi
measur
ofa
figur
show
ri
strainbytreat
strain
predict
interv
stereotypi
centroid
ep
figur
present
raw
data
strainbytreat
predict
bodi
weight
rix
mice
treat
haloperidol
placebo
figur
show
cc
strainlevel
predict
plasma
haloperidol
level
figur
compar
pretreat
distribut
variou
behavior
measur
ccrix
cc
diallel
studi
crowley
et
al
survey
mous
strain
crowley
et
al
crowley
et
al
file
includ
sampl
code
studi
use
rix
mice
deriv
genet
divers
cc
order
understand
effect
haloperidolinduc
adr
use
batteri
behavior
test
mean
comprehens
phenotyp
character
maxim
genet
divers
test
outbr
mice
reproduc
genom
gener
rix
mice
cross
male
femal
two
differ
cc
ri
strain
figur
quasiloop
design
figur
quasiloop
design
use
ri
genom
avail
time
gener
mostli
uniformli
structur
popul
potenti
expand
analyt
possibl
beyond
simpl
addit
model
provid
systemat
approach
detect
regulatori
variat
includ
parentoforigin
effect
perform
batteri
behavior
test
mice
rix
line
deriv
cc
strain
treat
haloperidol
placebo
order
monitor
develop
adr
figur
detail
phenotyp
pipelin
studi
mice
enter
phenotyp
pipelin
week
age
behavior
assay
carri
detail
materi
method
provid
descript
well
modelbas
result
behavior
phenotyp
examin
use
ccrix
ccrix
mice
exhibit
reduc
open
field
activ
chronic
treatment
haloperidol
ccbi
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
raw
data
visual
margin
strainspecif
level
seri
densiti
plot
figur
illustr
densiti
phenotyp
open
field
activ
decreas
preto
posttreat
mice
treat
placebo
haloperidol
figur
visual
leftshift
distribut
curv
phenotyp
except
stereotypi
figur
expect
cohort
mice
known
spend
less
time
explor
open
field
chamber
reexpos
due
lack
novelti
distanc
travel
figur
figur
vertic
activ
figur
figur
leftshift
far
pronounc
haloperidol
treat
mice
suggest
strong
averag
treatment
effect
leftshift
modest
time
centroid
figur
figur
observ
stereotypi
figur
figur
note
impli
lack
margin
effect
stereotypi
although
raw
data
suggest
treatment
effect
mean
treatment
still
affect
individu
rix
strain
differ
see
raw
data
inclin
screen
test
figur
suggest
extrem
effect
haloperidol
pretreat
placebotr
mice
seri
cluster
around
zero
mice
move
almost
immedi
place
inclin
screen
convers
distribut
haloperidol
treat
mice
bimod
exhibit
extrem
fat
right
tail
enrich
notic
proport
anim
unabl
move
four
paw
within
experi
raw
data
vcm
visual
distribut
curv
figur
haloperidoltr
rix
mice
show
increas
suscept
emerg
vcm
evidenc
fatten
right
tail
haloperidol
seri
placebo
seri
note
small
notic
proport
anim
treatment
paradigm
experi
vcm
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
median
differ
median
visual
monoton
increas
seri
red
dot
chronic
haloperidol
exposur
diverg
effect
across
ofa
measur
distanc
travel
vertic
activ
half
rix
line
display
reduct
ofa
measur
haloperidol
exposur
figur
less
quarter
rix
line
display
chang
stereotypi
figur
centroid
durat
figur
seem
unaffect
line
raw
data
ep
show
major
rix
line
show
delay
respons
inclin
screen
test
haloperidol
treatment
figur
lastli
raw
data
vcm
measur
show
half
rix
line
display
higher
incid
vcm
haloperidol
treatment
figur
main
model
result
tabl
includ
result
eight
phenotyp
assay
experi
eas
readabl
pvalu
also
explicitli
list
rather
level
signific
simpli
indic
asterisk
colorcod
first
five
row
tabl
contain
fix
effect
estim
pvalu
parenthes
pvalu
comput
use
kenwardrog
approxim
comput
denomin
degre
freedom
next
four
row
contain
estim
varianc
compon
interest
batch
effect
exclud
pvalu
comput
likelihood
ratio
test
lrt
next
four
row
correspond
test
statist
pvalu
involv
multipl
paramet
number
row
correspond
fix
effect
fstatist
row
correspond
test
random
effect
likelihood
ratio
statist
one
salient
result
strong
margin
fix
effect
treatment
highli
signific
phenotyp
confirm
result
exploratori
analys
signific
centroid
stereotypi
model
howev
weakli
signific
model
bodi
weight
note
howev
strain
effect
highli
signific
model
includ
centroid
stereotypi
random
treatment
effect
also
signific
phenotyp
except
bodi
weight
figur
main
model
result
includ
tabl
provid
evid
exist
strain
strainbytreat
interact
howev
determin
parent
ri
strain
ccbi
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
contribut
also
interest
ie
interest
level
random
effect
estim
varianc
compon
use
blup
strain
level
predict
plot
ascend
order
phenotyp
figur
absolut
height
bar
correspond
predict
interv
due
small
number
sampl
per
rix
littl
power
differenti
ri
effect
compar
two
strain
predict
interv
tend
overlap
except
compar
strain
extrem
assumpt
addit
strain
effect
strainlevel
predict
use
predict
rix
line
exhibit
extrem
phenotyp
leverag
inform
across
phenotyp
find
strain
consist
extrem
predict
use
inform
actual
inform
futur
experi
select
strain
extrem
result
show
strain
predict
correl
across
phenotyp
strainbytreat
interact
assess
correl
use
pearson
correl
coeffici
present
result
correlogram
figur
first
panel
appli
strain
predict
second
strainbytreat
interact
note
blood
haloperidol
concentr
appear
second
panel
although
relev
random
effect
term
strain
effect
model
phenotyp
predict
haloperidoltr
mice
addit
strain
effect
two
salient
result
distanc
vertic
bodi
weight
phenotyp
correl
chang
horizont
distanc
correl
highli
chang
vertic
beam
broken
strain
largest
decreas
phenotyp
exhibit
smallest
increas
weight
expect
two
open
field
phenotyp
exhibit
correl
vcm
increas
time
spent
centroid
associ
fewer
vcm
increas
stereotypi
associ
increas
vcm
correl
manifest
strainbytreat
effect
well
effect
treatment
chang
distanc
vertic
centroid
effect
correl
effect
treatment
chang
distanc
time
spent
centroid
invers
proport
effect
treatment
bodi
weight
studi
employ
genet
divers
ccrix
mice
elucid
genet
basi
antipsychot
adr
perform
batteri
behavior
test
mice
rix
line
treat
haloperidol
placebo
order
monitor
develop
adr
ccrix
line
display
widerang
respons
haloperidol
treatment
induc
adr
captur
ccbi
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
preand
postdrug
behavior
measur
averag
treatment
strong
effect
everi
phenotyp
except
centroid
stereotypi
howev
note
even
phenotyp
signific
betweenstrain
variabl
major
ccrix
line
exhibit
reduc
distanc
travel
vertic
activ
upon
haloperidol
treatment
third
rix
line
exhibit
littl
chang
measur
exposur
haloperidol
figur
centroid
time
stereotypi
measur
appear
sensit
haloperidol
induc
respons
figur
major
rix
line
show
delay
respons
inclin
screen
test
ep
haloperidol
treatment
figur
half
rix
line
display
higher
incid
vcm
haloperidol
treatment
figur
interestingli
preval
adr
ccrix
popul
analog
observ
human
patient
treat
antipsychot
develop
tardiv
dyskinesia
halliday
et
al
soaresweis
fernandez
use
linear
mix
model
test
exist
strain
treatment
effect
note
phenotyp
model
includ
pretreat
fix
effect
demonstr
signific
regress
mean
subject
higher
pretreat
score
experienc
larger
reduct
phenotyp
observ
highli
signific
strain
effect
almost
behavior
measur
investig
p
observ
strong
strainbytreat
interact
phenotyp
particularli
strong
effect
p
chang
distanc
travel
chang
vertic
activ
well
chang
ep
view
blup
import
keep
mind
given
small
sampl
size
parent
strain
comparison
effect
individu
pair
parent
strain
necessarili
signific
even
overal
effect
highli
signific
draw
closer
attent
treatment
effect
blup
indic
strain
extrem
phenotyp
substanti
mean
shift
figur
figur
direct
consist
mean
shift
rightmost
column
tabl
flag
strain
extrem
find
strain
extrem
respons
least
one
phenotyp
eight
extrem
multipl
phenotyp
despit
extens
effort
limit
understand
herit
motor
adr
human
zhang
malhotra
drago
et
al
crowley
et
al
shown
tabl
estim
herit
phenotyp
measur
use
ccrix
rang
chang
bodi
weight
number
vcm
chang
distanc
travel
use
similar
chronic
haloperidol
treatment
paradigm
genet
divers
inbr
strain
previous
show
haloperidolinduc
adr
includ
vcm
ep
highli
herit
strain
major
predictor
phenotyp
variat
ccbi
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
independ
haloperidol
plasma
level
crowley
et
al
discrep
herit
estim
found
vcm
studi
like
due
genet
divers
present
ccrix
compar
inbr
line
lower
herit
found
ccrix
h
like
closer
herit
analog
trait
td
human
one
major
goal
studi
identifi
specif
gene
drive
antipsychot
adr
ccrix
mice
open
field
phenotyp
attempt
genet
map
use
broman
et
al
two
way
first
use
pretreat
phenotyp
depend
variabl
control
sex
also
use
chang
baselin
depend
variabl
control
pretreat
phenotyp
sex
treatment
interact
thereof
detect
lod
peak
exceed
signific
threshold
establish
base
permut
inabl
find
signific
associ
unexpect
trait
appear
polygen
would
like
need
much
larger
sampl
size
achiev
enough
power
map
also
explor
genet
architectur
behavior
measur
use
diallel
cross
eight
genet
divers
founder
strain
cc
shown
varianc
ep
explain
parentoforigin
addit
effect
crowley
et
al
compar
pretreat
distribut
phenotyp
compar
data
avail
data
diallel
cross
aforement
survey
mous
strain
see
figur
distribut
larg
accord
expect
distanc
vertic
phenotyp
right
tail
rix
distribut
thicker
sampl
consist
expect
hybrid
vigor
pattern
observ
vcm
convers
mice
strain
survey
dataset
heaviest
enrich
nzo
sampl
specif
bred
express
phenotyp
studi
support
use
ccrix
mous
popul
pharmacogenom
studi
observ
ccrix
mice
exhibit
sensit
haloperidol
exposur
evidenc
vcm
ep
close
match
proport
human
develop
td
treatment
antipsychot
given
signific
impact
antipsychot
adr
subsequ
discontinu
treatment
patient
make
headway
understand
genet
basi
suscept
antipsychot
adr
could
advanc
develop
safer
effect
therapeut
approach
treatment
schizophrenia
ccbi
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
thank
highthroughput
sequenc
facil
system
genet
core
unc
assist
project
pf
report
follow
financi
interest
current
lundbeck
advisori
committe
grant
recipi
past
three
year
pfizer
scientif
advisori
board
directli
relat
research
present
paper
ccbi
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
figur
order
gener
rix
line
maximum
genet
divers
test
anim
per
rix
line
male
haloperidol
placebo
femal
haloperidol
placebo
b
mice
hous
two
per
cage
wean
one
design
drug
treatment
placebo
treatment
avoid
batch
effect
rix
line
test
across
three
batch
c
rix
mice
age
week
ad
phenotyp
pipelin
phenotyp
occur
predrug
day
pellet
implant
acut
drug
treatment
day
one
day
split
pellet
implant
chronic
treatment
haloperidol
placebo
chronic
drug
day
pellet
implant
open
field
activ
ofa
done
predrug
chronic
drug
treatment
inclin
screen
test
measur
extrapyramid
side
effect
ep
done
predrug
acut
drug
treatment
vacuou
chew
movement
vcm
measur
chronic
drug
treatment
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
placebo
halop
ridol
differ
median
cc
rix
line
chang
vertic
activ
beam
bro
ken
placebo
halop
ridol
differ
median
ccbi
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
